| Net Cash Provided by (Used in) Operating Activities |
$10,525 |
USD |
-13% |
Q4 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$10,525 |
USD |
13% |
Q4 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
75,000,000 |
shares |
0% |
Q4 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
2,752,667 |
shares |
0% |
Q4 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$0 |
USD |
|
Q4 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$47,486 |
USD |
37% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$47,486 |
USD |
37% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$226,126 |
USD |
37% |
Q3 2025 |
FY 2025 |
| Additional Paid in Capital |
$75,519 |
USD |
0% |
Q4 2025 |
Q1 2026 |
| Amortization of Intangible Assets |
$0 |
USD |
-100% |
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q3 2025 |
FY 2025 |
| Interest Expense |
$11,332 |
USD |
52% |
Q4 2025 |
Q1 2026 |